Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: an update on risk stratification, molecular genetics, and therapeutic approaches including allogeneic hematopoietic stem cell transplantation

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2015, Pages e398-e412

  Odenike, Olatoyosi ^a   Onida, Francesco ^a   Padron, Eric ^a  

^a SECTION OF HEMATOLOGY ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MOLECULAR BIOLOGY; MYELODYSPLASTIC SYNDROMES; PROCEDURES; PROGNOSIS; RISK FACTOR;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MOLECULAR BIOLOGY; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RISK FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84965183857     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.14694/EdBook_AM.2015.35.e398     Document Type: Review

References (0)